Stephen Gresham Henry, M.D., M.Sc. for UC Davis Health

Stephen Gresham Henry, M.D., M.Sc.

Associate Professor, Division of General Medicine, Geriatrics, and Bioethics

To see if Stephen Gresham Henry is accepting new patients, or for assistance finding a UC Davis doctor, please call 800-2-UCDAVIS (800-282-3284).



Internal Medicine


Locations and Contact

Lawrence J. Ellison Ambulatory Care Center

General Internal Medicine
4860 Y St.
Sacramento, CA 95817

Get Directions

Phone: 916-734-2737

Additional Numbers

Clinic Fax


Physician Referrals

800-4-UCDAVIS (800-482-3284)

Philosophy of Care

My goal is to provide high-quality, non-judgmental care to patients.

Clinical Interests

Dr. Henry is a general internist who offers care to adults in both the inpatient and outpatient (primary care) settings. He has special clinical interests in chronic pain management.

Research/Academic Interests

Dr Henry's research interests include: patient-clinician communication; chronic pain management; primary care; controlled substance epidemiology; prescription drug monitoring programs; overdose prevention; patient experience.


General Medicine

Center/Program Affiliation

Center for Healthcare Policy and Research

Undergraduate School

A.B., Chemistry, Harvard University, Cambridge MA 2000

Medical School

M.D., Vanderbilt University School of Medicine, Nashville TN 2006

Other School

M.Sc., Health and Healthcare, University of Michigan, Ann Arbor MI 2010


Internal Medicine, University of Michigan, Ann Arbor MI 2006-2009


RWJ Clinical Scholars Program, University of Michigan, Ann Arbor MI 2009-2012

Alpha Omega Alpha, 2005

Matthias MS, Henry SG. Reducing Frustration and Improving Management of Chronic Pain in Primary Care: Is Shared Decision-making Sufficient? J Gen Intern Med. 2022 Jan;37(1):227-228. doi:10.1007/s11606-021-06967-3. Epub 2021 Jun 25. PMID:34173195.

White AEC, Hood-Medland EA, Kravitz RL, Henry SG. Visit Linearity in Primary Care Visits for Patients with Chronic Pain on Long-term Opioid Therapy. J Gen Intern Med. 2022 Jan;37(1):78-86. doi:10.1007/s11606-021-06917-z. Epub 2021 Jun 22. PMID:34159543.

Henry SG, Shev AB, Crow D, Stewart SL, Wintemute GJ, Fenlon C, Wirtz SJ. Impacts of prescription drug monitoring program policy changes and county opioid safety coalitions on prescribing and overdose outcomes in California, 2015-2018. Prev Med. 2021 Dec;153:106861. doi:10.1016/j.ypmed.2021.106861. Epub 2021 Oct 20. PMID:34687731.

Tseregounis IE, Tancredi DJ, Stewart SL, Shev AB, Crawford A, Gasper JJ, Wintemute G, Marshall BDL, Cerdá M, Henry SG. A Risk Prediction Model for Long-term Prescription Opioid Use. Med Care. 2021 Dec 1;59(12):1051-1058. doi:10.1097/MLR.0000000000001651. PMID:34629423.

Henry SG, Stewart SL, Murphy E, Tseregounis IE, Crawford AJ, Shev AB, Gasper JJ, Tancredi DJ, Cerdá M, Marshall BDL, Wintemute GJ. Using Prescription Drug Monitoring Program Data to Assess Likelihood of Incident Long-Term Opioid Use: a Statewide Cohort Study. J Gen Intern Med. 2021 Dec;36(12):3672-3679. doi:10.1007/s11606-020-06555-x. Epub 2021 Mar 19. PMID:33742304.

Tseregounis IE, Henry SG. Assessing opioid overdose risk: a review of clinical prediction models utilizing patient-level data. Transl Res. 2021 Aug;234:74-87. doi:10.1016/j.trsl.2021.03.012. Epub 2021 Mar 21. PMID:33762186.

Fenton JJ, Magnan EM, Agnoli AL, Henry SG, Xing G, Tancredi DJ. Longitudinal Dose Trajectory Among Patients Tapering Long-Term Opioids. Pain Med. 2021 Jul 25;22(7):1660-1668. doi: 10.1093/pm/pnaa470. PMID: 33738505.

Henry SG, Feng B, Verba S, Kravitz RL, Iosif AM. The story vs the storyteller: Factors associated with the effectiveness of brief video-recorded patient stories for promoting opioid tapering. Health Expect. 2021 Jun;24(3):991-999. doi:10.1111/hex.13243. Epub 2021 Apr 9. PMID:33835644.

Castillo-Carniglia A, González-Santa Cruz A, Cerdá M, Delcher C, Shev AB, Wintemute GJ, Henry SG. Corrigendum to "Changes in opioid prescribing after implementation of mandatory registration and proactive reports within California's prescription drug monitoring program" [Drug Alcohol Depend. 218 (2021) 108405]. Drug Alcohol Depend. 2021 Apr 1;221:108606. doi:10.1016/j.drugalcdep.2021.108606. Epub 2021 Feb 18. Erratum for: Drug Alcohol Depend. 2021 Jan 1;218:108405. PMID:33611026.